Healthcare -
Biotechnology - NASDAQ - US
$ 2.95
-10.3 %
$ 2.15 B
Market Cap
-3.28
P/E
IBRX - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities IBRX - ImmunityBio, Inc.
558 M
LAST VALUE
5.10%
2 YEAR CAGR
273.43%
5 YEAR CAGR
90.12%
10 YEAR CAGR